Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Grant Verstandig (Founder, Chairman and CEO of Red Cell Partners) and I explore this path forward in an op-ed in The Washington Post: #GLP1 #EmployerBenefits To view or add a comment, sign in More Relevant Posts For the 40.3 percent of Americans who are obese, GLP-1 medications have the real potential to dramatically improve lives, prevent chronic disease and reduce long-term health care costs
Advantages Over Direct GH Administration The rationale for using Sermorelin rather than direct growth hormone (GH) administration is based on several key advantages of working through the body's endogenous hormone system: Sermorelin stimulates pulsatile GH release that mimics natural physiological secretion patterns, with GH levels rising and falling in accordance with the body's circadian rhythms and metabolic needs, whereas exogenous GH provides constant supraphysiological levels that can override normal regulation
Several randomised controlled trials have demonstrated that GLP-1 agonists can reduce liver fat content and improve biochemical markers of liver injury
Highlights of Prescribing Label: Ozempic (semaglutide) injection, for subcutaneous use
